Skip to content. | Skip to navigation

IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.


The APGI BioResource

A key APGI priority is to continue to build capacity in translational research by acquiring biological material and clinico-pathological data for all types of pancreatic disease, which will provide an unparalleled base for ongoing studies. The APGI incorporates the NSW Pancreatic Cancer Network (2006-2010) and the Australian Familial Pancreatic Cancer Cohort (AFPaCC) (2011-2014).

Introduction & Availability

We have a range of snap frozen and formalin tissue, including tumour and matched normal tissue, and blood components for some cases. All BioSpecimens are accompanied by a wealth of clinical and pathological information.

Read More…

Accessing the APGI BioResource

Please read through this page carefully and familiarise yourself with our requirements. You'll find the download link for the APGI BioResource Request Form below.

Read More…

BioResource Request Form

Please download and complete this form only after you have initiated preliminary discussions with us at It is a condition of use that you acknowledge the APGI in any eventual publication arising from work using our resources.

Read More…

BioSpecimen Science

BioSpecimens are the link between molecular biology and cancer research. They allow researchers to study genomic and epigenomic abnormalities in the context of cancer disease development and progression.

Read More…